Cargando…
Bead-Based Isolation of Circulating Tumor DNA from Pancreatic Cancer Patients Enables High Fidelity Next Generation Sequencing
INTRODUCTION: Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive cancers and poses a challenge to the treating clinician. With the emergence of genomic profiling technologies, circulating tumor DNA (ctDNA) is increasingly recognized as a versatile biomarker for risk stratification...
Autores principales: | Balendran-Braun, Sukirthini, Kieler, Markus, Liebmann-Reindl, Sandra, Unseld, Matthias, Bianconi, Daniela, W Prager, Gerald, Streubel, Berthold |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8357621/ https://www.ncbi.nlm.nih.gov/pubmed/34393517 http://dx.doi.org/10.2147/CMAR.S308029 |
Ejemplares similares
-
Genetic diagnosis and clinical evaluation of severe fetal akinesia syndrome
por: Reischer, Theresa, et al.
Publicado: (2020) -
Biochemical and genetic predictors of overall survival in patients with metastatic pancreatic cancer treated with capecitabine and nab-paclitaxel
por: Bianconi, Daniela, et al.
Publicado: (2017) -
Genetic association in female stress urinary incontinence based on proteomic findings: a case-control study
por: Reischer, Theresa, et al.
Publicado: (2019) -
Cross-over comparison and new chemotherapy regimens in metastatic pancreatic cancer
por: Kieler, Markus, et al.
Publicado: (2017) -
A real-world analysis of second-line treatment options in pancreatic cancer: liposomal-irinotecan plus 5-fluorouracil and folinic acid
por: Kieler, Markus, et al.
Publicado: (2019)